{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:15:08Z","timestamp":1772759708391,"version":"3.50.1"},"reference-count":32,"publisher":"Japanese Society of Hypertension","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1291\/hypres.29.627","type":"journal-article","created":{"date-parts":[[2007,2,9]],"date-time":"2007-02-09T05:41:24Z","timestamp":1170999684000},"page":"627-634","source":"Crossref","is-referenced-by-count":13,"title":["Effects of Eplerenone and Salt Intake on Left Ventricular Remodeling after Myocardial Infarction in Rats"],"prefix":"10.1291","volume":"29","author":[{"given":"Akihiro","family":"URABE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"IZUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"ABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"TANIGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seibu","family":"MOCHIZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pitt B, Zannad F, Remme WJ, <i>et al<\/i>, Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. <i>N Engl J Med<\/i> 1999; <b>341<\/b>: 709-717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000071081.35693.9A"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.781"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0005"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220120"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000015854.60710.10"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.303"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1097\/01.crd.0000148845.74124.c0"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2001.03586.x"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.447"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Martinez DV, Rocha R, Matsumura M, <i>et al<\/i>: Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. <i>Hypertension<\/i> 2002; <b>39<\/b>: 614-618.","DOI":"10.1161\/hyp.39.2.614"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)03268-5"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.925"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL: Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. <i>Hypertension<\/i> 2004; <b>43<\/b>: 1252-1257.","DOI":"10.1161\/01.HYP.0000128031.31572.a3"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200112088"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.865"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Delyani JA, Robinson EL, Rudolph AE: Effect of a selective aldosterone receptor antagonist in myocardial infarction. <i>Am J Physiol Heart Circ Physiol<\/i> 2001; <b>281<\/b>: H647-H654.","DOI":"10.1152\/ajpheart.2001.281.2.H647"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fraccarollo D, Galuppo P, Hildemann S, Christ M, Ertl G, Bauersachs J: Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. <i>J Am Coll Cardiol<\/i> 2003; <b>42<\/b>: 1666-1673.","DOI":"10.1016\/j.jacc.2003.05.003"},{"key":"20","unstructured":"20. Brilla CG, Weber KT: Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. <i>J Lab Clin Med<\/i> 1992; <b>120<\/b>: 893-901."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Brilla CG, Weber KT: Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. <i>Cardiovasc Res<\/i> 1992; <b>26<\/b>: 671-677.","DOI":"10.1093\/cvr\/26.7.671"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Weber KT, Janicki JS, Pick R, Capasso J, Anversa P: Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. <i>Am J Cardiol<\/i> 1990; <b>65<\/b>: 1G-7G.","DOI":"10.1016\/0002-9149(90)90952-W"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Young M, Fullerton M, Dilley R, Funder J: Mineralocorticoids, hypertension, and cardiac fibrosis. <i>J Clin Invest<\/i> 1994; <b>93<\/b>: 2578-2583.","DOI":"10.1172\/JCI117269"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rocha R, Rudolph AE, Frierdich GE, <i>et al<\/i>: Aldosterone induces a vascular inflammatory phenotype in the rat heart. <i>Am J Physiol Heart Circ Physiol<\/i> 2002; <b>283<\/b>: H1802-H1810.","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Rogacz S, Williams GH, Hollenberg NK: Time course of enhanced adrenal responsiveness to angiotensin on a low salt diet. <i>Hypertension<\/i> 1990; <b>15<\/b>: 376-380.","DOI":"10.1161\/01.HYP.15.4.376"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.8.3936"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Suzuki G, Morita, Mishima T, <i>et al<\/i>: Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. <i>Circulation<\/i> 2002; <b>106<\/b>: 2967-2972.","DOI":"10.1161\/01.CIR.0000039104.56479.42"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Takeda Y, Yoneda T, Demura M, Miyamori I, Mabuchi H: Cardiac aldosterone production in genetically hypertensive rats. <i>Hypertension<\/i> 2000; <b>36<\/b>: 495-500.","DOI":"10.1161\/01.HYP.36.4.495"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1210\/en.141.5.1901"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ye P, Kenyon CJ, Mackenzie SM, <i>et al<\/i>: The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart. <i>Endocrinology<\/i> 2005; <b>146<\/b>: 5287-5293.","DOI":"10.1210\/en.2005-0370"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000056769.73726.E5"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1130"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T13:29:57Z","timestamp":1556112597000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.29.627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.29.627","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}